Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.
[PURPOSE] Previous studies suggest that the clinical presentation of chronic obstructive pulmonary disease (COPD) is different between men and women.
- p-value p<0.0001
- HR 1.62
APA
Jestin-Guyon N, Ouaalaya EH, et al. (2026). Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.. International journal of chronic obstructive pulmonary disease, 21, 531894. https://doi.org/10.2147/COPD.S531894
MLA
Jestin-Guyon N, et al.. "Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.." International journal of chronic obstructive pulmonary disease, vol. 21, 2026, pp. 531894.
PMID
41847336
Abstract
[PURPOSE] Previous studies suggest that the clinical presentation of chronic obstructive pulmonary disease (COPD) is different between men and women. The aim of this study was to investigate sex-related differences and survival among COPD patients.
[PATIENTS AND METHODS] Multicentric prospective real-life cohort. COPD patients (post-bronchodilator FEV/FVC <0.7) of any stages of airway obstruction recruited since January 2014 by pulmonologists. Stratified logistic regression models assessed to identify the determinants of dyspnea, exacerbations, ABE classification and all-cause mortality by sex. Kaplan-Meier curves and Cox proportional-hazards models were also performed.
[RESULTS] A total of 3265 patients included, with 36.7% women. Women had an increased risk of ≥2 exacerbations (aOR=1.79; CI[1.46-2.19]), mMRC grade 1 (aOR=1.46; CI[1.14-1.89]) and grade 2 (aOR=1.41; CI[1.07-1.87]) and a higher risk of severity E of the ABE classification (aOR=1.56; CI[1.27-1.93]). In stratified models, the determinants of these outcomes were different. Men had a lower survival rate at GOLD airway obstruction I-II (Log-rank: p<0.0001) and III-IV (Log-rank: p<0.0001) and a higher risk of mortality (HR=1.62; CI[1.40-1.87]). Common factors characterizing mortality were: age, BMI <18.5, mMRC ≥ 2, airway obstruction, diabetes and lung cancer. Additional factors related to mortality in men were asthma, left heart failure and tobacco-related cancers.
[CONCLUSION] COPD is more severe in women however men have a higher risk of mortality. Clinical features and mortality in men and women with COPD are different in our cohort. Further studies are needed to elucidate sex-related differences among COPD patients.
[PATIENTS AND METHODS] Multicentric prospective real-life cohort. COPD patients (post-bronchodilator FEV/FVC <0.7) of any stages of airway obstruction recruited since January 2014 by pulmonologists. Stratified logistic regression models assessed to identify the determinants of dyspnea, exacerbations, ABE classification and all-cause mortality by sex. Kaplan-Meier curves and Cox proportional-hazards models were also performed.
[RESULTS] A total of 3265 patients included, with 36.7% women. Women had an increased risk of ≥2 exacerbations (aOR=1.79; CI[1.46-2.19]), mMRC grade 1 (aOR=1.46; CI[1.14-1.89]) and grade 2 (aOR=1.41; CI[1.07-1.87]) and a higher risk of severity E of the ABE classification (aOR=1.56; CI[1.27-1.93]). In stratified models, the determinants of these outcomes were different. Men had a lower survival rate at GOLD airway obstruction I-II (Log-rank: p<0.0001) and III-IV (Log-rank: p<0.0001) and a higher risk of mortality (HR=1.62; CI[1.40-1.87]). Common factors characterizing mortality were: age, BMI <18.5, mMRC ≥ 2, airway obstruction, diabetes and lung cancer. Additional factors related to mortality in men were asthma, left heart failure and tobacco-related cancers.
[CONCLUSION] COPD is more severe in women however men have a higher risk of mortality. Clinical features and mortality in men and women with COPD are different in our cohort. Further studies are needed to elucidate sex-related differences among COPD patients.
MeSH Terms
Humans; Pulmonary Disease, Chronic Obstructive; Male; Female; Aged; France; Sex Factors; Risk Factors; Middle Aged; Prospective Studies; Time Factors; Lung; Proportional Hazards Models; Severity of Illness Index; Forced Expiratory Volume; Kaplan-Meier Estimate; Health Status Disparities; Logistic Models; Disease Progression; Vital Capacity; Multivariate Analysis; Chi-Square Distribution; Prognosis; Dyspnea; Odds Ratio; Risk Assessment